Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus

  • 0Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Hospital Universitario Santa Cristina, IIS Hospital Universitario de La Princesa, 28009, Madrid, Spain. valenciafernandezines@gmail.com.

|

|

Summary

This summary is machine-generated.

COVID-19 infection triggers endothelial dysfunction, leading to hypercoagulation and hypofibrinolysis, especially in patients with diabetes mellitus. Therapeutic strategies targeting endothelial activation and antidiabetics may improve outcomes.

Area Of Science

  • Endocrinology
  • Infectious Diseases
  • Vascular Biology
  • Hematology

Background

  • COVID-19 infection causes endothelial dysfunction, characterized by endothelitis, hypercoagulation, and hypofibrinolysis.
  • Endothelial barrier activation exacerbates disease severity, contributes to long-COVID, and affects hemostasis.
  • Diabetic patients with pre-existing endothelial dysfunction face heightened risks from COVID-19-related vascular complications.

Purpose Of The Study

  • To review potential triggers of endothelial activation in COVID-19, particularly in the context of diabetes mellitus.
  • To explore the mechanisms underlying COVID-19-induced endothelial dysfunction and its impact on hemostasis.
  • To discuss therapeutic strategies for managing endothelial activation and hypercoagulable states in COVID-19 and diabetic patients.

Main Methods

  • Review of existing literature on COVID-19, endothelial dysfunction, and diabetes mellitus.
  • Analysis of molecular and cellular mechanisms involved in SARS-CoV-2-induced endothelial activation.
  • Examination of coagulation and fibrinolysis alterations in COVID-19 and diabetic patients.

Main Results

  • COVID-19 triggers endothelial activation via viral particles and immune responses (e.g., NF-κB/NLRP3 inflammasome, cytokine storm, NETosis).
  • Alterations in coagulation factors (e.g., factor VIII, fibrinogen) and impaired fibrinolysis contribute to hypercoagulation.
  • Diabetes mellitus exacerbates these mechanisms, leading to significant hemostasis loss.

Conclusions

  • Targeting activated endothelium with specific inhibitors (e.g., anti-thrombin, anti-cytokine) offers therapeutic potential.
  • Antidiabetic agents may mitigate endothelial dysfunction, inflammation, and platelet aggregation.
  • Improving microvascular pathology in COVID-19 and post-COVID patients can reduce comorbidity and mortality risks.

Related Concept Videos

Pathophysiology of Diabetes 01:20

935

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Psychoneuroimmunology: Diabetes and Cancer 01:19

29

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Overview of Carbohydrate Metabolism 01:19

1.0K

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

Anticoagulant Drugs: Low-Molecular-Weight Heparins 01:30

697

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Diabetes: Symptoms, Diagnosis, and Complications 01:15

539

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Diabetes Mellitus: Type 2 and Gestational 01:22

2.4K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...